Дата добавления
01.10.2017
Последняя актуализация
26.01.2023
Местоположение
Производственная площадка
················ ················ ············ ················ ········ ················
Краткое описание
В Центральном федеральном округе компания намерена инвестировать в строительство фармацевтического производства. Общая сумма вложений в проект составит порядка 3 млрд рублей. Реализовать его планируется до 2021 года. Мощность нового предприятия составит 11,5 кг фармсубстанции в год
Полное описание
······ ················ ······ ········ ············ ········ ······ ·············· ············ ················ ······ ·········· ········ ················ ······ ·········· ······ ·········· ·········· ············ ············ ······ ·············· ············ ·········· ·········· ·········· ·········· ·············· ·········· ···· ················ ········ ······ ········ ········ ······ ·············· ················ ············ ······ ········ ················ ················ ···· ······ ·············· ·········· ················ ·············· ················ ······ ···· ················ ················ ······ ······ ············ ······ ·········· ·········· ·············· ······ ·········· ············
Результаты интервью
···· ·················· ···· ····.····.········ ············ ···· ············ ·························· ······················ ········ ·········· ················ ······ ····················
···· ·················· ···· ····.····.········ ·········· ················ ······ ············ ·················· ···· ············ ···················· ·· ···························· ·········· ······ ·············· ·························· ················ ·········· ·················· ···················· ················ ·········· ·· ··············
·································· ························ ·························· ·················· ···· ························ ·························· ······················ ·························· ·········· ·········· ·············· ···· ············ ·········· ············ ···················· ················································ ·························································· ·················· ·· ···························· ································ ········ ···························· ························ ···· ············ ·········· ···················· ········ ·············· ················ ·················· ·················· ················ ·· ············ ···························· ···· ············ ·· ·············· ············ ·· ············ ···························· ························ ·· ······················ ···················· ·· ······················ ························································ ·········· ·························· ·············· ·· ·················· ························ ·········· ···················· ·········· ······················ ········ ·············· ························ ·························· ···················· ············ ···························· ·· ························ ························ ·· ·············· ·········· ·························· ················ ······ ······························ ·········· ·· ···················· ···· ·········· ·· ······················ ···················· ·································· ························ ···························· ·· ······ ············ ·················· ········ ·········· ·········· ················ ···· ············ ···· ···························· ············ ·· ······ ············ ········ ·········· ·························· ·········· ············ ······ ············ ·· ······ ············ ······ ················ ·· ················ ·························· ·················· ······ ············ ········ ··················
···· ·················· ···· ····.····.········ ······ ·················· ···· ······················ ·········· ···· ·················· ······················ ·········· ························ ········ ············ ········
···· ·················· ···· ····.····.········ ·············· ················ ···························· ···· ·················· ·········· ········ ···· ················
···· ·················· ···· ····.····.········ ········ ···························· ······ ······················ ················ ·· ···· ·············· ·················· ·············· ························ ···················· ·· ···· ··················
···· ·················· ···· ····.····.········ ······ ·········· ·················· ······ ·············· ·········································· ·············· ······ ······················ ···················· ···· ·················· ········································ ···· ·········· ································ ················ ···································· ·················· ·················· ···· ·········· ···················· ······················ ···· ·············· ············ ·· ·········· ·················· ······················ ·· ············ ·························· ······················
···· ·················· ···· ····.····.········ ········ ···························· ······ ···················· ······················ ·· ········ ················ ··········
···· ·················· ···· ····.····.········ ········ ···················· ··············
···· ·················· ···· ····.····.········ ············ ············
Объем инвестиций
······ ······
Холдинг инвестора
Сроки проекта
2017 — IV квартал, 2020 год
Отрасль
Подотрасль
Тип объекта/тип работ
Завод лекарственных средств/Новое строительство
Площадь объекта
············ ·········· ········
Площадь участка
············ ········
Вид собственности
Топ-25 отрасли
Топ-25 региона
Производственная мощность
········ ···· ·············· ···· ················ ················
Готовая продукция
······ ········ ·········· ················ ······ ·········· ······ ················ ············ ··············
Название
········ ·············· ···· ····
Холдинг
Основной вид деятельности (ОКВЭД)
············ ·········· ··············
Адрес
················ ········ ················ ···· ················ ······ ·········· ······ ············ ······ ····
Телефон
+·· (······) ······-····-····
Финансовые показатели (2022 г.)